Common Stock, Shares, Outstanding of Salarius Pharmaceuticals, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Salarius Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Salarius Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 944,491, a 34% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Salarius Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 944,491 -496,666 -34% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 2,127,286 +1,486,109 +232% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 2,081,839 -2,232,594 -52% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 96,077 -396,227 -80% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 1,441,157 -2,497,276 -63% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 641,177 -2,710,892 -81% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 4,314,433 +1,846,136 +75% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 492,304 -1,763,595 -78% 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q3 2023 3,938,433 +1,689,062 +75% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 3,352,069 -52,764,174 -94% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 2,468,297 -44,228,897 -95% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 2,255,899 +446,306 +25% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 2,249,371 -42,923,164 -95% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 56,116,243 +11,337,449 +25% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 46,697,194 +1,962,866 +4.4% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 1,809,593 -21,998,953 -92% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 45,172,535 +25,353,623 +128% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 44,778,794 +30,140,786 +206% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 44,734,328 +31,088,651 +228% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 23,808,546 +19,297,372 +428% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q3 2020 19,818,912 +16,062,728 +428% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 14,638,008 -3,430,634 -19% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 13,645,677 -4,422,340 -24% 31 Mar 2020 10-Q/A 15 May 2020 2020 Q1
Q4 2019 4,511,174 +2,478,411 +122% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 3,756,184 -14,310,583 -79% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 18,068,642 +2,500 +0.01% 30 Jun 2019 10-Q 17 Jul 2019 2019 Q2
Q1 2019 18,068,017 +87,165 +0.48% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 2,032,763 -15,764,415 -89% 31 Dec 2018 10-K 23 Mar 2020 2019 FY
Q3 2018 18,066,767 +525,390 +3% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 18,066,142 +780,216 +4.5% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 17,980,852 +951,603 +5.6% 31 Mar 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 17,797,178 +1,023,380 +6.1% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 17,541,377 +1,023,030 +6.2% 30 Sep 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 17,285,926 +1,025,145 +6.3% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 17,029,249 +1,024,503 +6.4% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 16,773,798 +1,032,180 +6.6% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q3 2016 16,518,347 +1,069,037 +6.9% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 16,260,781 +1,069,925 +7% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 16,004,746 +1,072,648 +7.2% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 15,741,618 +13,525,907 +610% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q3 2015 15,449,310 30 Sep 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 15,190,856 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 14,932,098 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 2,215,711 31 Dec 2014 10-K 08 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.